BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $576,000 | -4.5% | 7,153 | 0.0% | 0.18% | -10.2% |
Q1 2021 | $603,000 | +5.1% | 7,153 | +0.1% | 0.20% | -2.0% |
Q4 2020 | $574,000 | -0.2% | 7,145 | 0.0% | 0.20% | -8.3% |
Q3 2020 | $575,000 | +4.0% | 7,145 | +11.2% | 0.22% | -4.8% |
Q2 2020 | $553,000 | +5.9% | 6,423 | 0.0% | 0.23% | -8.8% |
Q1 2020 | $522,000 | -2.8% | 6,423 | 0.0% | 0.25% | +21.3% |
Q4 2019 | $537,000 | -4.4% | 6,423 | 0.0% | 0.21% | -8.4% |
Q3 2019 | $562,000 | +6.8% | 6,423 | 0.0% | 0.23% | +3.7% |
Q2 2019 | $526,000 | +0.6% | 6,423 | 0.0% | 0.22% | -2.2% |
Q1 2019 | $523,000 | +23.6% | 6,423 | 0.0% | 0.22% | +9.3% |
Q4 2018 | $423,000 | +5.0% | 6,423 | +23.0% | 0.20% | +16.6% |
Q3 2018 | $403,000 | +4.7% | 5,223 | 0.0% | 0.18% | -1.7% |
Q2 2018 | $385,000 | +13.2% | 5,223 | 0.0% | 0.18% | +11.2% |
Q1 2018 | $340,000 | +0.9% | 5,223 | 0.0% | 0.16% | +3.2% |
Q4 2017 | $337,000 | +2.7% | 5,223 | 0.0% | 0.16% | -2.5% |
Q3 2017 | $328,000 | +3.5% | 5,223 | 0.0% | 0.16% | -1.9% |
Q2 2017 | $317,000 | +17.0% | 5,223 | 0.0% | 0.16% | +15.7% |
Q1 2017 | $271,000 | +16.8% | 5,223 | 0.0% | 0.14% | +11.1% |
Q4 2016 | $232,000 | -17.1% | 5,223 | +30.6% | 0.13% | -26.3% |
Q2 2015 | $280,000 | +2.2% | 4,000 | 0.0% | 0.17% | +3.6% |
Q1 2015 | $274,000 | +20.7% | 4,000 | +22.7% | 0.16% | +15.4% |
Q4 2013 | $227,000 | – | 3,260 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |